Mologic Developing Sepsis Test Using Multimarker Lateral Flow Technology

By |2021-05-20T11:39:47+01:00September 20th, 2019|

Sep 20, 2019 | Leo O'Connor NEW YORK – Mologic is developing a multimarker point-of care diagnostic test using lateral flow technology that it anticipates launching in Europe next year. The diagnostic test, which is being evaluated as part of a University College London Hospitals (UCLH) study, is part [...]

Mologic and University College London Hospitals collaborating in major clinical trial for early detection of sepsis

By |2021-05-20T11:37:36+01:00September 13th, 2019|

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis Observational study led by Mervyn Singer, Professor of Intensive Care Medicine and Dr David Brealey, Consultant in Intensive Care Bedfordshire, UK, 13 September 2019: Mologic Ltd, a leading developer of lateral flow and [...]

Go to Top